The full abstract will be published online on April 25, 2025. More details about the programs for the AACR Annual Meeting 2025 are available online at AACR Annual Meeting 2025 | Meetings | AACR.

The first patient has been dosed in the phase 3 TACTI-004 trial evaluating efti with Keytruda and chemotherapy for advanced ...

Lung cancer is one of the most aggressive cancers, with a significantly higher global incidence and mortality rate than other cancer types. Although chemotherapy, radiation, and surgical removal are ...

Phase III IMvoke010 trial found that maintenance treatment with Tecentriq (atezolizumab) did not significantly improve ...

Thymic epithelial tumors are a rare group of malignancies originating in the thymus gland, that includes thymoma and thymic carcinoma.

NICE is unable to make a recommendation about the use in the NHS of atezolizumab (Tecentriq) for untreated advanced or recurrent non-small-cell lung cancer when platinum-doublet chemotherapy is ...

Additional Phase 2 data for vilastobart,a tumor-activated, Fc-enhanced anti-CTLA-4, in combination with atezolizumab in patients with MSS CRC ...

Giancarlo Oviedo-Mori was diagnosed with advanced lung cancer at the age of 18 — now 32, he is married and the father of a 2-year-old son, Josiah. It was a hot, humid night in 2010 when Giancarlo ...

And your lungs may work just as well as before, depending on your reason for surgery. Lung cancer commonly requires a lobectomy to remove parts of your lung called lobes. (Photo Credit ...